# Joerns Healthcare partners with MolecuLight for wound imaging technology

Joerns Healthcare announced an exclusive agreement with MolecuLight Corp. to add MolecuLight's fluorescence imaging technology (i:X and DX devices) to its wound management portfolio for point-of-care detection of bacterial burden in wounds.

- Type: Partnership
- Announced: 2021-10-19
- Where: United States
- Status: announced
- Products: fluorescence imaging devices, wound measurement platform
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [MolecuLight Inc.](https://endata.com/companies/41343.md) (partner)
- [Joerns Healthcare](https://endata.com/companies/58545.md) (partner)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/joerns-healthcare-introduces-point-of-care-imaging-to-wound-care-portfolio-through-moleculight-partnership-301403034.html), 2021-10-19: "We are thrilled to partner with Joerns Healthcare to provide long-term healthcare facilities with access to our imaging platform for their wound care needs."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.